semaglutide hf Has Similar Benefits in Women and Men With HFpEF Semaglutide Reduces Need for Diuretics

doi: 10.1038/ejcn.2014.165

View on NEJM U.S

In this guide, you will find: The dose ranges evaluated so far (112 mg weekly) How gradual titration influences outcomes and side-effect management Key distinctions between Retatrutide and other GLP-1/GIP agonists What upcoming data may suggest about its clinical and real-world potential Key Takeaways Retatrutide is an investigational triple-agonist medication that activates GLP-1, GIP, and glucagon receptors to improve metabolism and reduce appetite

Dosing can vary between pharmacies, so tracking your usage helps to determine whether the current formulation is working as expected or if side effects are stronger than they should be